SignatureFD’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.98K | Sell |
525
-45
| -8% | -$513 | ﹤0.01% | 2528 |
|
2025
Q1 | $6.77K | Hold |
570
| – | – | ﹤0.01% | 2486 |
|
2024
Q4 | $10.7K | Hold |
570
| – | – | ﹤0.01% | 2327 |
|
2024
Q3 | $12.8K | Hold |
570
| – | – | ﹤0.01% | 2235 |
|
2024
Q2 | $11.9K | Buy |
570
+87
| +18% | +$1.82K | ﹤0.01% | 2192 |
|
2024
Q1 | $7.1K | Sell |
483
-197
| -29% | -$2.9K | ﹤0.01% | 2426 |
|
2023
Q4 | $7.02K | Sell |
680
-226
| -25% | -$2.33K | ﹤0.01% | 2395 |
|
2023
Q3 | $7.12K | Sell |
906
-108
| -11% | -$849 | ﹤0.01% | 2361 |
|
2023
Q2 | $10.1K | Sell |
1,014
-10
| -1% | -$100 | ﹤0.01% | 2225 |
|
2023
Q1 | $9.09K | Buy |
1,024
+1,014
| +10,140% | +$9K | ﹤0.01% | 2256 |
|
2022
Q4 | $110 | Buy |
+10
| New | +$110 | ﹤0.01% | 3225 |
|
2022
Q2 | – | Sell |
-48
| Closed | -$1K | – | 3265 |
|
2022
Q1 | $1K | Buy |
48
+42
| +700% | +$875 | ﹤0.01% | 3020 |
|
2021
Q4 | $0 | Sell |
6
-13
| -68% | – | ﹤0.01% | 3212 |
|
2021
Q3 | $1K | Sell |
19
-7
| -27% | -$368 | ﹤0.01% | 2866 |
|
2021
Q2 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 2773 |
|